Los Angeles Capital Management LLC Simulations Plus, Inc. Transaction History

Los Angeles Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$38.46 - $50.95 $162,570 - $215,365	4,227 New	4,227 $205,000
Q2 2023 Aug 03, 2023	BUY	$40.45 - $48.0 $258,758 - $307,056	6,397 New	6,397 $277,000
Q2 2022 Aug 05, 2022	SELL	$40.55 - $51.76 $155,590 - $198,603	-3,837 Reduced 31.52%	8,337 $411,000
Q2 2021 Aug 05, 2021	BUY	$49.67 - $68.96 $604,682 - $839,519	12,174 New	12,174 $668,000
Q1 2021 May 05, 2021	SELL	$60.06 - $89.52 $346,426 - $516,351	-5,768 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$53.26 - $77.18 $161,644 - $234,241	3,035 Added 111.05%	5,768 $415,000
Q3 2020 Nov 02, 2020	BUY	$57.51 - $75.36 $157,174 - $205,958	2,733 New	2,733 $206,000
Q1 2019 Apr 25, 2019	SELL	$18.84 - $21.36 $279,491 - $316,875	-14,835 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$17.56 - $21.2 $3,950 - $4,770	-225 Reduced 1.49%	14,835 $295,000
Q3 2018 Nov 05, 2018	BUY	$17.1 - $23.55 $257,526 - $354,663	15,060 New	15,060 $304,000

175

15.1M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $584M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.